ArticleEplasty2024
Soft Tissue Support as an Adjunct to Implant-Based Cosmetic Breast Surgery: A 500+ Case Experience.
Article in Eplasty, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Clinical outcomes of synthetic absorbable mesh use in breast surgery: First case series in reconstruction and aesthetic mastopexy.JPRAS open · 2026Article
- Early Performance of a Multifilament Resorbable Synthetic Mesh in Aesthetic Breast Surgery: A 206 Patient Experience.Aesthetic surgery journal. Open forum · 2026Article
- Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Intraoperative techniques to maximize control are crucial to achieving an aesthetic result in cosmetic breast surgery with implants. The authors describe their experience with the use of polydioxanone (PDO) internal support matrix in a high volume of primary augmentation, primary mastopexy augmentation, and revision augmentation cases. Methods: A high-volume (n = 522) single-surgeon experience followed patient outcomes in consecutive cases from September 2020 to June 2023. All patients received smooth-shelled silicone gel breast implant augmentation surgeries with PDO mesh as an adjunct. Each case used at least 1 sheet of PDO mesh, with a small set (n = 9) receiving 2 sheets. Patients were followed (range 6-37 months), with 6 months minimum follow-up to assess outcomes. Results: PDO mesh is associated with decreased malposition in primary augmentation with smooth implants and improved scarring in primary and revision augmentations involving a mastopexy. Augmentations performed with PDO mesh as an adjunct allowed for the use of larger implant volumes with less concern over poor soft tissue stores and compromised skin quality to hold the weight of the implant. Conclusions: PDO mesh is a safe and effective adjunct to smooth silicone gel implants to obtain greater pocket control and optimal aesthetic results in cosmetic breast surgeries.
Indexed as
Identifiers
39474001PMC11520357What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.